{
    "title": "Novartis aims to expand Beovu use after safety fears hurt launch",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8730791/Novartis-aims-expand-Beovu-use-safety-fears-hurt-launch.html",
    "date": "2020-09-14",
    "keywords": [
        "beovu",
        "novartis",
        "safety",
        "dme",
        "eylea",
        "monday",
        "condition",
        "zurich",
        "vision",
        "clarity",
        "blindnesscausing",
        "eye",
        "drugmaker",
        "medicine",
        "addition",
        "acuity",
        "edema",
        "year",
        "treatment",
        "lessfrequent",
        "half",
        "dosing",
        "schedule",
        "statement",
        "approval",
        "data",
        "belief",
        "therapy",
        "sauer",
        "drug",
        "development",
        "degeneration",
        "blindness",
        "review",
        "society",
        "vasculitis",
        "occlusion",
        "sale",
        "riskbenefit",
        "agency",
        "label",
        "warning",
        "use",
        "officer",
        "harry",
        "kirsch",
        "july",
        "launch",
        "growth",
        "cause",
        "john",
        "miller",
        "editing",
        "thomas",
        "seythal"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}